Careers  |  Sign In  |  Register

Trending: Gout Diagnosis and Management

Course List

  • CME Information

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by an educational grant from Ironwood Pharmaceuticals, Inc.


Gout is an inflammatory arthritis characterized by the deposition of monosodium urate crystals in the joints, tendons, and other connective tissues. Approximately 8 million Americans are currently affected by gout, and that number continues to rise. Conditions such as hypertension, metabolic syndrome, type 2 diabetes mellitus, heart failure, organ transplant, obesity, medications, and chronic kidney disease promote an increased incidence of hyperuricemia and gout. Evidence-based guidelines for the diagnosis and treatment of gout differ among medical organizations. In addition, new therapies have been approved since the issuance of these guidelines, and physicians are challenged to apply the most evidence-based care when treating patients with hyperuricemia and gout. This CME activity will feature interviews, where experts discuss the pathophysiology, diagnosis, and management of gout according to the latest guidelines and recent therapeutic approvals.

Target Audience

This program is designed for primary care physicians, rheumatologists, and other health care professionals involved in the treatment of patients with gout.

Learning Objectives

Upon successful completion of these activities, participants should be better able to:

  • Review the pathophysiology, as well as etiologic and risk factors, associated with the development of gout.
  • Incorporate patient education and guidance into practice to improve adherence and compliance to prescribed therapeutic regimens.
  • Apply the evidence and best practices when diagnosing gout in everyday practice.
  • Use evidence-based guidelines and best practices when treating and monitoring hyperuricemia and gout.
  • Apply recent clinical data relating to mechanisms, efficacy, and safety of conventional and new treatment options to improve the overall outcomes of patients with hyperuricemia and gout.


Robert T. Keenan, MD, MPH, MBA
Associate Professor of Medicine
Vice Chief for Clinical Affairs, Division of Rheumatology
Director, Duke Gout and Crystal Arthropathy Clinic
Duke University School of Medicine
Durham, NC

Angelo L. Gaffo, MD, MSPH
Associate Professor of Medicine
Division of Rheumatology and Clinical Immunology
University of Alabama at Birmingham
Birmingham, AL


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™, 0.25 credits per video. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, July 19, 2018 to July 19, 2019.

How to Participate in this Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, watch the videos, and complete the CME posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly for each video. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Peer Reviewer

Paul P. Doghramji, MD


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below.

Faculty members report the following relationship(s):

Robert T. Keenan, MD, MPH, MBA
Consulting Fee: Horizon, Kowa, Sobi
Contracted Research: Sobi

Angelo L. Gaffo, MD, MSPH
Contracted Research: Amgen, AstraZeneca, Ironwood

Peer Reviewer reports the following relationship(s):

Paul P. Doghramji, MD
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s):

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at